Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Современные подходы к профилактике обострений у детей с атопическим дерматитом
Современные подходы к профилактике обострений у детей с атопическим дерматитом
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Атопический дерматит и инфекции кожи у детей: диагностика, лечение и профилактика. Научно-практическая программа. М., 2004.
2. Короткий Н.Г., Таганов А.В. Атопический дерматит у детей: принципы наружной терапии. Пособие для педиатра. Аллергические болезни. М., 2000.
3. Марголина А., Эрнандес Е., Зайкина О. Новая косметология. Косметика и медицина, 2002.
4. Миринова Л.Г. Медицинская косметология. М.: Крон-пресс, 2000.
5. Ревякина В.А. Современные аспекты этиологии патогенеза и лечения атопического дерматита у детей. Мед. совет. 2008; 1–2.
6. Сергеев А.Ю., Караулов А.В., Кудрявцева Е.В. Новые подходы к профилактике атопического дерматита. РМЖ. 2003; 11 (1): 3–6.
7. Смолкин Ю.С., Чебуркин А.А. Эффективность применения крема Экзомега при атопическом дерматите у детей. РМЖ. 2003; 11 (17): 976–80.
8. Современная наружная терапия дерматозов. Под ред. Н.Г.Короткого. Тверь: Губернская медицина, 2001.
9. Юрина Н.А., Радостина А.И. Кожа и ее производные. М., 1996.
10. Braback L, Kjellman N-I M, Sandin A, Bjorksten B. Atopy among schoolchildren in northern and souther Swedtn in relation to pet ownership and earli life events. Pediatr Allergy Immunol 2001; 12: 4–9.
11. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128–37.
12. Denda M, Sato J, Tsuchiya T et al. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 1998; 111: 873–8.
13. De Polo KF. A short textbook of cosmetology: Verlag fur chemische industrie. H.Ziolokowsky GmbH, 1998.
14. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27–30.
15. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatitis 1999; 10: 119–26.
16. Fox C. Topical bioactive materials. Cosmetics & Toiletries 1994; 109 (4): 83–114.
17. Ghadially R, Brown BE, Hanley K et al. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 1996; 106: 1064–9.
18. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558–64.
19. Holgate ST, Arshad SH. The year in allergy 2003. Oxford, 2003.
20. Josse M, Mengeaud V, Durosier V et al. Evaluation of the corticosteroid-sparing effect of an emollient in a large population of infants suffering from atopic dermatitis. Institut de Recherche Pierre Fabre, Ramonville Saint Agne, France; Pierre Fabre Dermo-Cosmetique, Lavaur, France; Servicio de Dermatologia, Hospital Clinico, Barcelona, Spain; Service de dermatologie, Hopital Nord, CHU Saint Etienne, France.
21. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860–76.
22. Linde YW. Dry skin in atopic dermatitis. Acta Derm Venereol 1992; 177 (Suppl. Stockh): 9–13.
23. Mao-Quiang M, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone treated murine skin. Arch Dermatol 1993; 129: 728–38.
24. Mao-Qiang M, Brown BE, Wu-Pong S et al. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995; 131: 809–16.
25. Matsumoto Y, Hamashima H, Masuda K et al. The antibacterial activity of plaunotol against Staphylococcus aureus isolated from the skin of patients with atopic dermatitis. Microbios 1998; 96: 149–55.
26. von Mutius E, Maziak W, Hirsch T, Beimfohr C et al. Asthma management and utilization of health care services in children: the results of a population – based survey. Eur Respir J 2001; 18 (Suppl. 33): 146.
27. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75: 429–33.
28. Solomon LM, Esterly NB. Neonatal dermatology. J Pediatr 1970; 77: 888–94.
29. Steinert PM, Cantieri JS, Teller DC et al. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci USA 1981; 78: 4097–101.
30. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985; 65: 102–5.
31. Williams HC et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international stude of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103: 125–38.
2. Короткий Н.Г., Таганов А.В. Атопический дерматит у детей: принципы наружной терапии. Пособие для педиатра. Аллергические болезни. М., 2000.
3. Марголина А., Эрнандес Е., Зайкина О. Новая косметология. Косметика и медицина, 2002.
4. Миринова Л.Г. Медицинская косметология. М.: Крон-пресс, 2000.
5. Ревякина В.А. Современные аспекты этиологии патогенеза и лечения атопического дерматита у детей. Мед. совет. 2008; 1–2.
6. Сергеев А.Ю., Караулов А.В., Кудрявцева Е.В. Новые подходы к профилактике атопического дерматита. РМЖ. 2003; 11 (1): 3–6.
7. Смолкин Ю.С., Чебуркин А.А. Эффективность применения крема Экзомега при атопическом дерматите у детей. РМЖ. 2003; 11 (17): 976–80.
8. Современная наружная терапия дерматозов. Под ред. Н.Г.Короткого. Тверь: Губернская медицина, 2001.
9. Юрина Н.А., Радостина А.И. Кожа и ее производные. М., 1996.
10. Braback L, Kjellman N-I M, Sandin A, Bjorksten B. Atopy among schoolchildren in northern and souther Swedtn in relation to pet ownership and earli life events. Pediatr Allergy Immunol 2001; 12: 4–9.
11. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128–37.
12. Denda M, Sato J, Tsuchiya T et al. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 1998; 111: 873–8.
13. De Polo KF. A short textbook of cosmetology: Verlag fur chemische industrie. H.Ziolokowsky GmbH, 1998.
14. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27–30.
15. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatitis 1999; 10: 119–26.
16. Fox C. Topical bioactive materials. Cosmetics & Toiletries 1994; 109 (4): 83–114.
17. Ghadially R, Brown BE, Hanley K et al. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 1996; 106: 1064–9.
18. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558–64.
19. Holgate ST, Arshad SH. The year in allergy 2003. Oxford, 2003.
20. Josse M, Mengeaud V, Durosier V et al. Evaluation of the corticosteroid-sparing effect of an emollient in a large population of infants suffering from atopic dermatitis. Institut de Recherche Pierre Fabre, Ramonville Saint Agne, France; Pierre Fabre Dermo-Cosmetique, Lavaur, France; Servicio de Dermatologia, Hospital Clinico, Barcelona, Spain; Service de dermatologie, Hopital Nord, CHU Saint Etienne, France.
21. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860–76.
22. Linde YW. Dry skin in atopic dermatitis. Acta Derm Venereol 1992; 177 (Suppl. Stockh): 9–13.
23. Mao-Quiang M, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone treated murine skin. Arch Dermatol 1993; 129: 728–38.
24. Mao-Qiang M, Brown BE, Wu-Pong S et al. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995; 131: 809–16.
25. Matsumoto Y, Hamashima H, Masuda K et al. The antibacterial activity of plaunotol against Staphylococcus aureus isolated from the skin of patients with atopic dermatitis. Microbios 1998; 96: 149–55.
26. von Mutius E, Maziak W, Hirsch T, Beimfohr C et al. Asthma management and utilization of health care services in children: the results of a population – based survey. Eur Respir J 2001; 18 (Suppl. 33): 146.
27. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75: 429–33.
28. Solomon LM, Esterly NB. Neonatal dermatology. J Pediatr 1970; 77: 888–94.
29. Steinert PM, Cantieri JS, Teller DC et al. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci USA 1981; 78: 4097–101.
30. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985; 65: 102–5.
31. Williams HC et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international stude of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103: 125–38.
Авторы
В.А.Ревякина
НИИ питания РАМН, Москва
НИИ питания РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.